Discover 1,928 paid clinical trials in Plano, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,928
Active & Responsive
RENAISSANCE 2: SPN-817 Phase 2, Double-Blind, Placebo-Controlled Study in Adults With Focal Onset Seizures
for
Focal Onset Seizures
Location: Frisco TX, Houston TX, Little Rock AR, Covington LA,
Sponsor: Supernus Pharmaceuticals, Inc.
Sex: All
Age: 18 - 70
Code: NCT06798896
Phase2, Recruiting
Active & ResponsiveNew
The GLOW Study: GLP-1 and Lifestyle for Optimal Wellness
for
Wellness
Location: The Colony TX
Sponsor: Saundra Jain
Sex: All
Age: 18+
Code: NCT07760896
Recruiting
Active & Responsive
Susan G. Komen's ShareForCures
for
Breast Cancer
Location: Dallas TX
Sponsor: Susan G. Komen Breast Cancer Foundation
Sex: All
Age: 18+
Code: NCT05654246
Recruiting
Active & Responsive
A Study To Learn About Two Study Medicines (PF-07275315 And PF-07264660) In People Who Have Moderate To Severe Atopic Dermatitis
for
Atopic Dermatitis
Location: Frisco TX, Dallas TX, Chickasha OK, Oklahoma City OK,
Sponsor: Pfizer
Sex: All
Age: 18+
Code: NCT05995964
Phase2, Recruiting
Active & Responsive
Wearable Photoplethysmography for Non-invasive Hydration Assessment
for
Hydration Status
Location: Frisco TX, Plano TX
Sponsor: PepsiCo Global R&D
Sex: All
Age: 18 - 45
Code: NCT07520344
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas
for
Triple Negative Breast Cancer, HER2-negative Breast Cancer,
Location: Dallas TX, Oklahoma City OK, Austin TX, San Antonio TX,
Sponsor: Dren Bio
Sex: All
Age: 18+
Code: NCT06999187
Phase1, Recruiting
Active & Responsive
Study to Investigate the Safety, Tolerability, Pharmacokinetics, Pharmocodynamics and Preliminary Antitumor Activity of AT-1965 in Patients With Advanced, Refractory or Recurrent Solid Tumors
for
Solid Tumor
Location: Dallas TX, Scottsdale AZ, El Segundo CA,
Sponsor: Alyssum Therapeutics
Sex: All
Age: 18+
Code: NCT06234098
Phase1, Phase2, Recruiting
Active & Responsive
A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
for
Moderate to Severe Chronic Obstructive Pulmonary Disease
Location: Dallas TX, St Louis MO, Birmingham AL, Atlanta GA,
Sponsor: Washington University School of Medicine
Sex: All
Age: 18+
Code: NCT05552157
Phase2, Phase3, Recruiting
Active & Responsive
A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)
for
Breast Neoplasms
Location: Dallas TX, Fort Worth TX, Tyler TX, San Antonio TX,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06312176
Phase3, Recruiting
Active & Responsive
A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011)
for
Triple Negative Breast Neoplasms
Location: Dallas TX, Houston TX, San Antonio TX, Hattiesburg MS,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06841354
Phase3, Recruiting
Active & Responsive
A Phase 3 Study of Pelabresib (DAK539) and Ruxolitinib in Myelofibrosis (MF)
for
Primary Myelofibrosis (PMF),
Location: Dallas TX, Tyler TX, Houston TX, Atlanta GA,
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 18+
Code: NCT07357727
Phase3, Recruiting
Active & Responsive
Skin Wetting in Burn Survivors
for
Burn Injury
Location: Dallas TX
Sponsor: University of Texas Southwestern Medical Center